- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 1/36 - ExtractionSeparationPurification by a combination of two or more processes of different types
Patent holdings for IPC class C07K 1/36
Total number of patents in this class: 1173
10-year publication summary
|
73
|
74
|
95
|
98
|
109
|
127
|
98
|
86
|
75
|
38
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4727 |
66 |
| Genentech, Inc. | 4110 |
34 |
| EMD Millipore Corporation | 631 |
27 |
| Amgen Inc. | 4429 |
24 |
| Takeda Pharmaceutical Company Limited | 2710 |
18 |
| Genzyme Corporation | 1367 |
14 |
| Bristol-myers Squibb Company | 4751 |
13 |
| Plasma Technologies, LLC | 25 |
13 |
| Green Cross Corporation | 220 |
12 |
| AbbVie Biotechnology Ltd. | 178 |
11 |
| CSL Behring AG | 186 |
10 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 298 |
10 |
| Sartorius Stedim Biotech GmbH | 875 |
10 |
| Abbvie Inc. | 1824 |
8 |
| The Catholic University of America | 99 |
8 |
| Agency for Science, Technology and Research | 3736 |
7 |
| Green Cross Holdings Corporation | 51 |
7 |
| Cytiva BioProcess R&D AB | 324 |
7 |
| F. Hoffmann-La Roche AG | 7819 |
6 |
| Hoffmann-La Roche Inc. | 3796 |
6 |
| Other owners | 862 |